Asset vs asset
Ripple USD is a stablecoin liquidity rail with $1.44B in market cap, while Injective is a INJ market beta asset with $303.19M. The useful comparison is market role, liquidity, seven-day direction, and which follow-up page gives the cleaner next decision.
Comparison Table
| Question | Ripple USD | Injective |
|---|---|---|
| Market role | stablecoin liquidity rail | INJ market beta asset |
| Price | $0.999993 | $3.03 |
| Market cap | $1.44B | $303.19M |
| 24h volume | $159.77M | $38.31M |
| 7d change | +0.01% | -1.11% |
| Relative size | Ripple USD is 4.74x Injective's market cap | Injective is 0.21x Ripple USD's market cap |
| Volume comparison | Ripple USD trades at 4.17x Injective's 24h volume | Injective trades at 0.24x Ripple USD's 24h volume |
Use the market-cap calculator when the real question is what one asset would imply at another size.
Open calculatorA cleaner comparison still needs a practical plan for exchanges, withdrawals, and wallets.
Open checklistPut both names back into the wider market context before treating the comparison as a final answer.
Open markets